BBSRC MIBTP - Artificial metalloproteins as novel MRI contrast agents
Dr M M Britton
6 January 2019
Since MRI’s first clinical applications nearly thirty years ago, MRI has become an essential tool for clinical diagnosis. Image contrast is routinely enhanced by the use of a contrast agent (CA), with the overwhelming majority based on complexes of gadolinium, and more recently manganese.
Using hyperpolarisation with MRI to track in vivo chemical changes
Dr A Kennerley, Prof S Duckett
9 January 2019
The newly proven technique of “spin hyperpolarised” Magnetic Resonance (MR) has the potential to become a safe and uniquely versatile high-sensitivity tool for medical research, drug discovery, clinical diagnostics and the probing of chemical change more generally.